[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "High disabled and LD deaths", "description": "US\n\nStorms \n\nFederal vaccination centres open\n\nDoses given, 55,792,000\n\nSecond dose, 15,192,000 (4.65%)\n\nHospitalizations, 64,535\n\nPast 7 days\n\nhttps://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=sf_coronavirus\n\nNew daily reported cases, down 23.7%\n\nNew daily reported deaths, down 7.6%\n\nCoViD related hospitalizations, down 18.4%\n\nTest positivity rate, 5.5%\n \nhttps://covidtracking.com/data\n\nONS data\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19roundup/2020-03-26\n\nAntibodies to COVID-19\n\n28 days up to 1st February\n\nEngland\n\n18.5% of the population\n\n8.3 million people aged 16 years and over\n\nOver 80 years, 40.9%\n\nWales\n\n14.4%\n\nNorthern Ireland\n\n13.6% \n\nScotland\n\n11.7%\n\nCases, W/E 6th February\n\nEngland\n\nPrevalence, 1 in 80\n\nEquating to 695,400 people\n\n(W/E 30th January, 846,900 people)\n\nWales\n\nOne in 85\n\nNorthern Ireland\n\nOne in 75 people\n\nScotland\n\nOne in 150 people\n\nDeaths, W/E 5th February\n\n+ 7,320 for the week\n\nDown 1,113 deaths compared with the previous week\n\nCOVID-19 still accounted for 42.6% of all deaths in England and Wales\n\nDisabled people\n\n24 January to 20 November 2020 \n\nAt greater risk of death\n\nMen\n\nNot disabled x 1\n\nDisabled x 1.9\n\nMore disabled x 3.1\n\nWomen\n\nNot disabled x 1\n\nDisabled x 2\n\nMore disabled x 3.5\n\nLearning disability, risk of death\n\nAge adjusted risk, x 3.5\n\n\nZimbabwe, vaccine\n\nhttps://www.chronicle.co.zw/covid-19-vaccination-starts-tomorrow-health-workers-to-go-first/\n\nMonday, 200 000 doses of vaccines donated by China\n\n600 000 doses to arrive next month\n\nVaccines from Russia, India, United Kingdom on their way\n \nhttps://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html#sinopharm\n\n79.34%\n\n2 doses, 3 weeks apart\n\nBeijing Institute of Biological Products\n\nInactivated coronavirus vaccine\n\nApproved in China, UAE, Hungary\n\nChina, 1 million doses given\n\nNo phase 3 publication\n\nOngoing in UAE, Morocco, Peru\n\nUAE, full approval, 86%\n\nChinese researchers, tested against variant B.1.351\n\nAntibody response, only modestly weaker\n\n Not yet published\n\n\nIsrael\n\nSA variant, 44\n\nReinfections with SA variant, 3\n\nGovernment, planning to launch a green certificate\n\nEnable vaccine recipients to enter public spaces, stadiums, concert halls, performance venues\n\nPurim on Feb. 25\n\nFrance\n\nhttps://www.franceinter.fr/societe/covid-19-veran-inquiet-du-developpement-des-variants-bresilien-et-sud-africain-notamment-en-moselle\n\nSA and Brazil variants, 5% of cases\n\nMostly in east\n\nMore vaccination doses sent\n\n\nWHO approved vaccines\n\nCovax programme\n\nPfizer\n\nOxford AZ, India\n\nOxford AZ, South Korea\n\nAll adults, all ages\n\n150 million doses of AZ, first quarter\n\n2 billion vaccine doses this year\n\n92 lower income countries\n\nDr Alejandro Cravioto, WHO's Strategic Advisory Group of Experts on Immunization\n\nThere is no reason not to recommend its use even in countries that have circulation of the variant\n\n\nTim Spector\n\nhttps://www.youtube.com/watch?v=RWnq86B5t3s\n\n450,000 first vaccine logs\n\nEven split, Pfizer and AZ\n\nSide effects\n\nPfizer, under 15% systemic symptoms\n\nBoth vaccines, higher if people have had the infection\n\nMore reactions younger and female\n\nMay not want to be having the vaccine within a few months of infection\n\nMay not need a vaccine this round\n\nAZ\n\nLess arm pain \n\nMore systemic side effects\n\nTwice as many people report systemic side effects\n\nOne to two days\n\nMild allergic reactions\n\nPfizer, 1%\n\nAZ, 2.5%\n\nRashes\n\nSwelling of the eyes\n\nFairly reassuring\n\nLevels of protection (Pfizer only so far)\n\nNo protection at all for 13 days\n\n21 to 30 days for full protection\n\n68% reduction in new infections\n\nLess severe disease if infected\n\n\n\nAustralia\n\nCase by case, individual clinical discretion\n\nNo efficacy issue in older people, just a possible futility issue for a small number\n \nhttps://www.youtube.com/watch?v=BLKb8W83wYY\n \nMeasured approach, 91% vaccine acceptance\n\n https://www.theguardian.com/australia-news/2021/feb/16/two-thirds-of-australians-definitely-want-covid-vaccine-while-27-are-unsure\n \n Dr Susan", "link": "https://www.youtube.com/watch?v=ApiGENgkcm0", "date_published": "2021-02-17 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Post vaccine deaths", "description": "Correction\n\n58-year old immunocompetent male\n\nImmunocompromised\n\nSevere reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report \n\nhttps://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab129/6132402\n\nAntibody-dependent enhancement\nAlso\n\nConvergent evolution\n\nCoevolution\n\nhtttps://vaers.hhs.gov\n\nhttps://vaers.hhs.gov/reportevent.html\n\nDecember 14, 2020, to February 7, 2021\n\nOver 41 million doses of COVID-19 vaccines administered in the United States\n\nVAERS received 1,170 reports of death (0.003%) among people who received a COVID-19 vaccine \n\nCDC and FDA physicians review each case report of death as soon as notified\n\nCDC requests medical records to further assess reports\n\nA review of available clinical information\n\nDeath certificates\n\nAutopsy reports\n\nMedical records\n\nRevealed no link with vaccination\n\nCDC and FDA will continue to investigate reports of adverse events, including deaths, reported to VAERS.\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html\n\nCOVID-19 vaccines are safe and effective.\n\nMillions of people in the United States have received COVID-19 vaccines, and these vaccines will undergo the most intensive safety monitoring in U.S. history.\n\nCDC recommends you get a COVID-19 vaccine as soon as you are eligible.\n\nCDC, FDA, and other federal partners will continue to monitor the safety of the COVID-19 vaccines\n\nCoronavirus vaccine \u2013 weekly summary of yellow card reporting\n\nhttps://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#analysis-of-data\n\nVaccination is the single most effective way to reduce deaths and severe illness from COVID-19.\n \nThe number and nature of suspected adverse reactions reported so far are not unusual in comparison to other types of routinely used vaccines\n\nThe overall safety experience with both vaccines is so far as expected from the clinical trials\n\nBased on current experience, the expected benefits of both COVID-19 vaccines in preventing COVID-19 and its serious complications far outweigh any known side effects\n\nAs with all vaccines and medicines, the safety of COVID-19 vaccines is being continuously monitored\n\nEvents with a fatal outcome\n\nBased on age-stratified all-cause mortality in England and Wales\n\nSeveral thousand deaths are expected to have occurred, \n\nnaturally, \n\nwithin 7 days\n\nof the many millions of doses of vaccines administered so far\n\nMHRA\n\nPfizer/BioNTech \n\n143 UK reports, patient died shortly after vaccination\n\nOxford University/AstraZeneca\n\n90 reports of deaths\n\nMajority in elderly, underlying illness\n\nReview of individual reports, does not suggest the vaccine played a role in the death\n\nAustralia vaccination\n\nScott Morrison, 80,000 people a week from the end of February\n\nGreg Hunt, 1 million doses a week from the end of March\n\nPopulation, 26 million\n\nPfizer approved last month\n\nAllowed to leave Europe\n\n20 million doses\n\n142,000 doses landed on Monday, starting next Monday, 22nd February\n\nBorder Force officers, hotel quarantine workers, Aged Care residents and workers\n\nhttps://www.abc.net.au/news/2021-02-16/coronavirus-astrazeneca-vaccine-approved-for-use-in-australia/13115784\n\nApproved Oxford AstraZeneca\n\nSecured 53.8 million doses\n\nProduced in Melbourne (50 million)\n\nVaccine most Australians will get\n\nTherapeutic Goods Administration (TGA)\n\nApproved for use over 18 years\n\nPeople over the age of 65 demonstrated a strong immune response\n\nOver 65s, case-by-case basis\n\nNo upper age limit\n\nTwo does, 12 weeks apart, minimum 4 weeks\n\nFive priority groups\n\nhttps://www.abc.net.au/news/2021-02-05/when-will-you-get-the-covid-19-vaccine/13112610\n\nGreen passports", "link": "https://www.youtube.com/watch?v=SHH1vWD19Fw", "date_published": "2021-02-16 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]